KPIs & Operating Metrics(New)
Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Consolidated Net IncomeCost of RevenueEBITEBITDAEBTEPS (Basic)EPS (Weighted Average and Diluted)Gross ProfitIncome from Continuing OperationsIncome from Non-Controlling InterestsIncome towards Parent CompanyInterest & Investment IncomeInterest ExpensesNet Income towards Common StockholdersNon Operating IncomeOperating ExpensesOperating IncomeOther Non Operating IncomeProfit After TaxRevenueSelling, General & AdministrativeTax ProvisionsTax Rate
Others
Ratios

Procter & Gamble (PG) EBT (2016 - 2025)

Historic EBT for Procter & Gamble (PG) over the last 17 years, with Q4 2025 value amounting to $5.4 billion.

  • Procter & Gamble's EBT fell 725.41% to $5.4 billion in Q4 2025 from the same period last year, while for Dec 2025 it was $20.6 billion, marking a year-over-year increase of 611.92%. This contributed to the annual value of $20.2 billion for FY2025, which is 749.43% up from last year.
  • As of Q4 2025, Procter & Gamble's EBT stood at $5.4 billion, which was down 725.41% from $6.0 billion recorded in Q3 2025.
  • Over the past 5 years, Procter & Gamble's EBT peaked at $6.0 billion during Q3 2025, and registered a low of $3.6 billion during Q2 2021.
  • Over the past 5 years, Procter & Gamble's median EBT value was $4.6 billion (recorded in 2024), while the average stood at $4.7 billion.
  • Over the last 5 years, Procter & Gamble's EBT had its largest YoY gain of 3000.44% in 2024, and its largest YoY loss of 1140.99% in 2024.
  • Over the past 5 years, Procter & Gamble's EBT (Quarter) stood at $5.2 billion in 2021, then fell by 7.71% to $4.8 billion in 2022, then dropped by 7.01% to $4.5 billion in 2023, then soared by 30.0% to $5.8 billion in 2024, then dropped by 7.25% to $5.4 billion in 2025.
  • Its last three reported values are $5.4 billion in Q4 2025, $6.0 billion for Q3 2025, and $4.5 billion during Q2 2025.